Stanley Tuhrim, MD Email Stanley Tuhrim
- PROFESSOR EMERITUS | Neurology
- Cerebrovascular Diseases / Stroke
- Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
- Stroke Center 212-241-7076 212-241-7076
Stanley Tuhrim, MD is Emeritus Professor of Neurology, and Geriatrics and Palliative Medicine in the Icahn School of Medicine at Mount Sinai. He is also the former Director of the Mount Sinai Stroke Center, which is recognized as a comprehensive stroke center by the Joint Commission.
Dr. Tuhrim received a BA from Haverford College and an MD from Mount Sinai School of Medicine. He completed an internship at the Hospital of the University of Pennsylvania, a neurology residency at Mount Sinai, and a fellowship in cerebrovascular disease at the University of Maryland, before joining the faculty at the University of Maryland in 1984, where he also pursued graduate studies in computer science. He returned to Mount Sinai in 1987 to organize the Gustave L. Levy Acute Stroke Unit and develop Mount Sinai’s Stroke Program which now includes six vascular neurologists and four fellows. Under his leadership, Mount Sinai was among the first to obtain ACGME approval for its Stroke Fellowship and New York State Department of Health designation as a Stroke Center.
Dr. Tuhrim’s research interests include computer-assisted medical decision-making and disease management, stroke epidemiology, and clinical trials. He was the principal investigator of the Minorities Risk Factors and Stroke Study (MRFASS) which identified and compared risk factors for stroke and recurrent stroke among African-Americans, Latinos, and non-Latino whites. In cooperation with Mount Sinai’s Department of Health Policy, Dr. Tuhrim led a project to determine the extent of underuse of proven stroke prevention therapies and implement and test an intervention to remedy this. He has been a participant in multiple acute ischemic stroke and intracerebral hemorrhage trials.
Neurology, American Board of Psychiatry and Neurology
MD, Mount Sinai School of Medicine
Residency, Internal Medicine
Hospital of The University Of Penn.
Mount Sinai Hospital
Fellowship, Cerebrovascular Disease
University of Maryland
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tuhrim during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Abbott Vascular Laboratories
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.